Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.640
-0.030 (-1.12%)
At close: Jan 16, 2026
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 509.69 million as of January 16, 2026. Its market cap has decreased by -23.99% in one year.
Market Cap
509.69M
Enterprise Value
778.58M
Revenue
741.27M
Ranking
n/a
PE Ratio
15.66
Stock Price
2.64
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 509.69M, a decrease of -26.16%. That is a compound annual growth rate of -6.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 509.69M | -2.91% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | 690.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.51B |
| Pro Medicus | 21.56B |
| Cochlear | 17.49B |
| Sonic Healthcare | 11.51B |
| Ramsay Health Care | 8.47B |
| Ansell | 4.84B |
| Telix Pharmaceuticals | 3.78B |
| Mesoblast | 3.48B |